Interindividual variation in the levels of certain urinary polycyclic aromatic hydrocarbon metabolites following medicinal exposure to coal tar ointment

Biomarkers

Volumn 2, Issue 5, 1997, Pages 321-327

  Bowman, Elise D ^a   Rothman, Nathaniel ^b   Hackl, Christian ^c   Santella, Regina M ^d   Weston, Ainsley ^a,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d NIOSH CDC ^*  (United States)

^e NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Benzo a pyrene; Biomonitoring; Carcinogen; Metabolism; Pyrene

Indexed keywords

EID: 0001517022     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475097231553     Document Type: Article

References (46)

1. AMES, B. N., MCCANN, J. AND YANASKI, E. (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Research, 31, 347-364.
2. ARISE, F., VERKAIK, M., HOORNWEG, G. P., VAN DE NESSE, R. J., JUKEMA-LEENSTRA, S. R., HOFSTRAAT, J. W., GOOIJER, C. AND VELTHORST, N. H. (1994) Trace analysis of 3-hydroxybenzo[a]pyrene in urine for the biomonitoring of human exposure to polycyclic aromatic hydrocarbons. Journal of Analytical Toxicology, 18, 195-203.
3. AUTRUP, H. AND SEREMET, T. (1986) Excretion of benzo[a]pyrene-gua adduct in the urine of benzo[a]pyrene-treated rats. Chemico-biological Interactions, 60, 217-226.
4. BICKERS, D. R. (1981) The carcinogenicity and mutagenicity of therapeutic coal tar: a perspective. Journal of Investigative Dermatology, 77, 173-174.
5. BOWMAN, E. D., SHIELDS, P. G., POIRIER, M. C., SANTELLA, R. M., MANCHESTER, D. K., FARMER, P. B., HARRIS, C. C. AND WESTON, A. (1990) Determination of complete fluorescence excitation-emission matrices for polycyclic aromatic hydrocarbon-DNA adducts found in human lung and placenta. Proceedings of the American Association for Cancer Research. p. 89, A526.
6. BOWMAN, E. D., ROTHMAN, N., SANTELLA, R. M., PERERA, F. P. AND WESTON, A. (1993) Detection of metabolites of polycyclic aromatic hydrocarbons in the urine of psoriasis patients treated topically with coal tar. Proceedings of the American Association for Cancer Research. p 163, A972.
7. BRIDGES, B. A., GREAVES, M., POLANI, P. E. AND WALD, N. (1981) Do treatments available for psoriasis patients carry a genetic or carcinogenic risk? Mutation Research, 86, 279-304.
8. BUCKLEY, T. J. AND LIOY, P. J. (1992) An examination of the time course from human dietary exposure to polycylcic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. British Journal of Industrial Medicine, 49, 113-124.
9. CONOVER, W. J. AND IMAN, R. L. (1981) Rank transformation as a bridge between parametric and nonparametric statistics. American Statistician, 35, 124-129.
10. DAS, M., BICKERS, D. R., SANTELLA, R. M. AND MUKHTAR, H. (1985) Altered patterns of cutaneous xenobiotic metabolism in UVB-induced squamous cell carcinoma in SKH-1 hairless mice. Journal of Investigative Dermatology, 84, 532-536.
11. GOECKERMAN, W. H. (1925) Treatment of psoriasis. Northwest Medicine, 24, 229-231.
12. GRANOLA, M. AND CLONFERO, E. (1992) Sensitivity of different bacterial assays in detecting mutants in urine of humans exposed to PAH. Mutation Research, 268, 131-137.
13. GUENGERICH, F. P. (1992) Metabolic activation of carcinogens. Pharmacological Therapeutics, 54, 17-61.
14. HANSEN, A. M., POULSEN, O. M., CHRISTENSEN, J. M. AND HANSEN, S. H. (1993) Assessment of occupational PAH exposure by biological monitoring of metabolities in urine. Proceedings of the 13th International Symposium on Polynuclear Aromatic Hydrocarbons, Bordeaux, France, P. Garrigues and M. Lamotte, eds (Gordon and Breach Science Publishers), pp. 1015-1022.
15. HARRIS, C. C. (1987) Human tissues and cells in carcinogenesis research. Cancer Research 47, 1-10.
16. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (1973) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Certain polycyclic aromatic hydrocarbons and heterocyclic compounds, Vol. 3 (IARC, Lyon).
17. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (1985) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Polynuclear aromatic compounds, part IV: bitumens, coal tars and derived products, shale-oils and soots, Vol. 35 (IARC, Lyon).
18. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (1985) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man: Tobacco smoking, Vol. 38 (IARC, Lyon).
19. JONGENEELEN, F. J., ANZION, R. B. M., LEIJDEKKERS, C-M., BOS, R. P. AND HENDERSON, P. T. (1985) 1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product. International Archives of Occupational and Environmental Health, 57, 47-55.
20. JONGENEELEN, F. J., ANZION, R. B. M. AND HENDERSON, P. T. (1987) Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. Journal of Chromatography, 413, 227-232.
21. JONGENEELEN, F. J., AKKER, W. V. D., BOS, R. P., ANZION, R. B. M., THEUWS, J. L. G., ROELOFS, H. M. J. AND HENDERSON, P. T. (1988) 1-Hydroxypyrene as an indicator of the mutagenicity of coal tar after activation with human liver preparations. Mutation Research, 204, 195-201.
22. KANG, D.-H., ROTHMAN, N., POIRIER, M. C., GREENBERG, A., HSU, C. H., SCHARTZ, B. S., BASER, M. E., GROOPMAN, J. D., WESTON, A. AND STRICKLAND, P. T. (1995) Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycylcic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis, 16, 1079-1085.
23. MOY, L. S., CHALET, M. AND LOWE, N. J. (1986) Scrotal squamous cell carcinoma in a psoriatic patient treated with coal tar. Journal of the American Academy of Dermatology, 14, 518-519.
24. MUKHTAR, H., DELTITO, B. J., MATGOURANIS, P. M., DAS, M., ASOKAN, P. AND BICKERS, D. R. (1986) Additive effects of ultraviolet B and crude coal tar on cutaneous carcinogen metabolism; possible relevance to the tumorigenicity of the Goeckerman regimen. Journal of Investigative Dermatology, 87, 348-353.
25. PHILIPS, D. H. (1983) Fifty years of benzo[α]pyrene. Nature (London), 303, 468-472.
26. PITTELKOW, M. R., PERRY, H. O., MULLER, S. A., MAUGHAN, W. Z. AND O'BRIEN, P. C. (1981) Skin cancer in patients with psoriasis treated with coal tar. Archives of Dermatology, 117, 465-468.
27. POIRIER, M. C. AND WESTON, A. (1996) Human DNA adduct measurements: state of the art. Environmental Health Perspectives, 104, 883-893.
28. RICE, J. E., HOSTED, T. J. AND LAVOIE, E. J. (1984) Fluoranthene and pyrene enhance benzo[a]pyrene-DNA adduct formation in vivo in mouse skin. Cancer Letters, 24, 327-333.
29. SANTELLA, R. M., LIN, C. D., CLEVELAND, W. L. AND WEINSTEIN, I. B. (1984) Monoclonal antibodies to DNA modified by an benzo[α]pyrene diol epoxide. Carcinogenesis, 5, 373-377.
30. SANTELLA, R. M., NUNES, M. G., BLASKOVIC, R., PERERA, F. P., TANG, D., BEACHMAN, A., LIN, J.-H. AND DELEO, V. A. (1994) Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. Cancer Epidemiology, Biomarkers and Prevention, 3, 137-140.
31. SCHALLER, K. H., ANGERER, J. AND HAUSMANN, N. (1993) The determination of 1-hydroxypyrene in urine as a tool for the biological monitoring of PAH-exposed persons. Proceedings of the 13th International Symposium on Polynuclear Aromatic Hydrocarbons, Bordeaux, France, P. Garrigues and M. Lamotte, eds (Gordon and Breach Science Publishers), pp. 1023-1030.
32. SHIELDS, P. G., BOWMAN, E. D., HARRINGTON, A. M., DOAN, V. T. AND WESTON, A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Research, 53, 3486-3492.
33. SHOU, M., KORZEKWA, K. R., CRESPI, C. L., GONZALEZ, F. J. AND GELBOIN, H. V. (1994) The role of 12 cDNA-expressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Molecular Carcinogenesis, 10, 159-168.
34. SITHISARANKUL, P., VINEIS, P., KANG, D., ROTHMAN, N., CAPOSASO, N. E. AND STRICKLAND, P. T. (1997) Association of 1-hydroxypyrene-glucuronide in human urine with cigarette smoking and broiled or roasted meat consumption. Biomarkers (in press).
35. STERN, R. S., ZIERLER, S. AND PARRISH, J. A. (1980) Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet, 1, 732-735.
36. STERN, R. S., SCOTTO, J. AND FEARS, T. R. (1985) Psoriasis and susceptibility to nonmelanoma skin cancer. Journal of the American Academy of Dermatology, 12, 67-73.
37. STORER, J. S., DELEON, I., MILLIKAN, K. E., LASETER, J. L. AND GRIFFING, C. (1984) Human absorption of crude coal tar products. Archives of Dermatology, 120, 874-877.
38. STRICKLAND, P. T., KANG, D.-H., BOWMAN, E. D., FITZWILLIAM, A., DOWNING, T. E., ROTHMAN, N., GROOPMAN, J. D. AND WESTON, A. (1994) Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis, 15, 483-487.
39. TOLA, S. (1980) Occupational cancer of the urinary bladder. Journal of Toxicology and Environmental Health, 6, 1253-1260.
40. TORINUKI, W. AND TAGAMI, H. (1988) Incidence of skin cancer in Japanese psoriatic patients treated with either methoxypsoralen phototherapy, Goeckerman regimen, or both therapies. Journal of the American Academy of Dermatology, 18, 1278-1281.
41. VAN DUUREN, B. L. AND GOLDSCHMIDT (1976) Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. Journal of the National Cancer Institute, 56, 1237-1242.
42. VAN MAANEN, J. M. S., MOONEN, E. J. C., MAAS, L. M., KLEINJANS, J. C. S. AND VAN SCHOOTEN, F. J. (1994) Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat. Carcinogenesis, 15, 2263-2268.
43. WESTON, A., BOWMAN, E. D., CARR, P., ROTHMAN, N. AND STRICKLAND, P. T. (1993) Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis, 14, 1053-1055.
44. WESTON, A., SANTELLA, R. M. AND BOWMAN, E. D. (1994) Detection of polycyclic aromatic hydrocarbon metabolites in urine from coal tar treated psoriasis patients and controls. Polycyclic Aromatic Hydrocarbons, 5, 241-247.
45. WHEELER, L. A., SAPERSTEIN, M. D. AND LOWE, N. J. (1981) Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light. Journal of Investigative Dermatology, 77, 181-185.
46. WRIGHT, C. W., LATER, D. W., PELROY, R. A., MAHLUM, D. D. AND WILSON, B. W. (1985) Comparative chemical and biological analysis of coal tar-based therapeutic agents to other coal-derived material. Journal of Analytical Toxicology, 5, 80-88.